Epigral is India's 4th largest manufacturer of Caustic Soda, Chlorine and Hydrogen and a leading manufacturer of Caustic Potash, Chloromethanes and Hydrogen Peroxide.
Epigral is strengthening its position in the specialty chemical segment by expanding CPVC Resin capacity to 75,000 TPA, setting up CPVC compound capacity of 35,000 TPA, entering into the Chlorotoluene & value chain and setting up R & D centre.
The company said it has launched first research and development centre at Ahmedabad spread over 14,374 square metres with an initial investment of Rs 30 crore.
PE is attractive at 18.17, lower than its sector PE ratio of 104.49.
Annual Revenue rose 41.24%, in the last year to Rs 2,196.38 Crores. Its sector's average revenue growth for the last fiscal year was 16.95%.
Annual Net Profit rose 39.76% in the last year to Rs 353.29 Crores. Its sector's average net profit growth for the last fiscal year was 4.91%.
Promoter Share Holding remains same at 71.38%.
Worth holding the stock for 2-3 Years !!!
Epigral is strengthening its position in the specialty chemical segment by expanding CPVC Resin capacity to 75,000 TPA, setting up CPVC compound capacity of 35,000 TPA, entering into the Chlorotoluene & value chain and setting up R & D centre.
The company said it has launched first research and development centre at Ahmedabad spread over 14,374 square metres with an initial investment of Rs 30 crore.
PE is attractive at 18.17, lower than its sector PE ratio of 104.49.
Annual Revenue rose 41.24%, in the last year to Rs 2,196.38 Crores. Its sector's average revenue growth for the last fiscal year was 16.95%.
Annual Net Profit rose 39.76% in the last year to Rs 353.29 Crores. Its sector's average net profit growth for the last fiscal year was 4.91%.
Promoter Share Holding remains same at 71.38%.
Worth holding the stock for 2-3 Years !!!